Skip to Content

Building Solar in Spain Instead of Germany Could Save Billions

Building solar and wind projects in the wrong place is wasting billions of dollars in Europe.

Siemens says it would make sense to build solar power plants in sunny countries in Europe rather than in cloudy ones. And wind turbines should be built in windy places.

These blindingly obvious suggestions run contrary to what’s actually happening. For example, a solar panel in Spain generates about twice as much electricity as the same-size solar panel in Germany because the sun shines on it more (here’s an graphic). But last year nearly half of all solar panels installed in Europe were installed in Germany, and only a small fraction were installed in Spain (see “The Great German Energy Experiment”).

Siemens calculates that if you were to install solar panels and wind turbines where the natural resources are best, and then string power lines to convey to the power to where it’s needed, you could save about $60 billion dollars by 2030 because you could install fewer of them. That savings figure accounts for the cost of the power lines (see “Supergrids”).

Europe isn’t the only place where solar is taking off in strange places. One of the major markets for solar power in the U.S. is New Jersey, which gets far less sun than the southwest U.S., but has policies that favor solar power.

Keep Reading

Most Popular

open sourcing language models concept
open sourcing language models concept

Meta has built a massive new language AI—and it’s giving it away for free

Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.